Syndion
Commercial- Indications
- Autism spectrum disorder, Nutritional deficiencies
Company intelligence / Profile preview
Yasoo Health develops science-based nutraceuticals targeting chronic disease management through improved nutrient absorption and antioxidant support. Its lead products have demonstrated benefits in pilot studies for children with autism spectrum disorder and patients with cystic fibrosis. The company collaborates with academic institutions on research and has commercialized its main supplement lines internationally.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yasoo Health.